WithdrawnNot Applicable

The Effect of Yogurt in Cancer Patient With Moderate Gastrointestinal (GI) Symptoms

Stopped: 0 patient accrual

United States0Started 2022-03-01

Plain-language summary

The goal of this clinical research study is to learn if probiotics found in yogurt can help to decrease gastrointestinal (GI) symptoms in cancer patients. Probiotics are live bacteria and yeast that help with many of our functions and may help digestive problems. Researchers also want to learn if the bacteria in your stool change as your symptoms change while eating yogurt.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Cancer patient
✓. 18 years old or older
✓. Has gastrointestinal symptoms with severity score of \</= 60 out of 100 visual analog scale for irritable bowel syndrome (VAS-IBS) in at least 2 out of 7 items measured
✓. Able to eat by mouth
✓. Estimated length of hospital stay is 10 days or more
✓. Must give written study consent

Exclusion criteria

✕. Neutropenic patient with absolute neutrophil count (ANC) less than 1000 cells/mm3
✕. Patient within 100 days of auto /allo stem cell transplant and their stem cell physician does not approve yogurt ingestion.
✕. Has intestinal obstruction.
✕. Patient is currently on antibiotics
✕. Allergic to yogurt
✕. Patient who eats yogurt equal or more than once a day in the last 3 days.

What they're measuring

Percentage Change in Bacteroidetes in Stool from Baseline to Day 12

Timeframe: Baseline to Day 12

Percentage Change in Firmicutes in Stool from Baseline to Day 12

Timeframe: Baseline to Day 12

Trial details

NCT IDNCT03177681

SponsorM.D. Anderson Cancer Center

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-03-21

View on ClinicalTrials.gov More Malignant Neoplasms of Independent (Primary) Multiple Sites trials